Lingru Xue

2.2k total citations
29 papers, 1.5k citations indexed

About

Lingru Xue is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Lingru Xue has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Lingru Xue's work include Prostate Cancer Treatment and Research (12 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (6 papers). Lingru Xue is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (6 papers). Lingru Xue collaborates with scholars based in United States, China and Singapore. Lingru Xue's co-authors include Ralph W. deVere White, Clifford G. Tepper, Xu-Bao Shi, Hsing-Jien Kung, Ai-Hong Ma, Joy C. Yang, Christopher P. Evans, Xu Ma, Jianjun Zhao and Xu‐Bao Shi and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Lingru Xue

28 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingru Xue United States 16 1.2k 795 267 104 97 29 1.5k
Ellen van Rooijen United States 15 791 0.7× 409 0.5× 103 0.4× 159 1.5× 170 1.8× 22 1.2k
Ian Giddings United Kingdom 19 889 0.8× 329 0.4× 106 0.4× 208 2.0× 213 2.2× 22 1.3k
Adnan Derti United States 16 1.1k 0.9× 183 0.2× 73 0.3× 108 1.0× 117 1.2× 20 1.3k
Yuko Matsushita Japan 17 377 0.3× 283 0.4× 234 0.9× 120 1.2× 25 0.3× 59 1.1k
Valery Tarasov Germany 10 1.4k 1.2× 1.2k 1.5× 48 0.2× 164 1.6× 77 0.8× 11 1.6k
Michael Mitchell United Kingdom 9 1.7k 1.5× 468 0.6× 118 0.4× 402 3.9× 227 2.3× 12 2.1k
Christer Einvik Norway 21 1.1k 0.9× 496 0.6× 38 0.1× 131 1.3× 93 1.0× 29 1.3k
Véronique Fafeur France 25 1.1k 1.0× 241 0.3× 99 0.4× 371 3.6× 152 1.6× 47 1.8k
Edwin H. Rodriguez United States 6 1.0k 0.9× 431 0.5× 65 0.2× 150 1.4× 92 0.9× 8 1.4k
Terhi Jokilehto Finland 12 481 0.4× 475 0.6× 65 0.2× 140 1.3× 95 1.0× 14 797

Countries citing papers authored by Lingru Xue

Since Specialization
Citations

This map shows the geographic impact of Lingru Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingru Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingru Xue more than expected).

Fields of papers citing papers by Lingru Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingru Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingru Xue. The network helps show where Lingru Xue may publish in the future.

Co-authorship network of co-authors of Lingru Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Lingru Xue. A scholar is included among the top collaborators of Lingru Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingru Xue. Lingru Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuzuoğlu‐Öztürk, Duygu, Hao G. Nguyen, Lingru Xue, et al.. (2025). Small-molecule RNA therapeutics to target prostate cancer. Cancer Cell. 43(5). 841–855.e8. 3 indexed citations
2.
Liu, Yitao, Yang Bao, Zelin Ma, et al.. (2024). Neoadjuvant Immunotherapy Combined with Chemoradiation in Esophageal Cancer: An Individual Patient Data Meta-Analysis. International Journal of Radiation Oncology*Biology*Physics. 120(2). e467–e467.
3.
4.
Xu, Yichen, Peiwei Huangyang, Ying Wang, et al.. (2021). ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance. Cell. 184(20). 5215–5229.e17. 111 indexed citations
5.
Nguyen, Hao G., Crystal S. Conn, Lingru Xue, et al.. (2018). Development of a stress response therapy targeting aggressive prostate cancer. Science Translational Medicine. 10(439). 115 indexed citations
6.
Leapman, Michael, Hao G. Nguyen, Janet E. Cowan, et al.. (2018). Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy. European Urology. 74(5). 668–675. 22 indexed citations
7.
Shi, Xu-Bao, Ai-Hong Ma, Lingru Xue, et al.. (2015). miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src. Cancer Research. 75(24). 5309–5317. 61 indexed citations
8.
Amir, Sumaira, Ai-Hong Ma, Xu-Bao Shi, et al.. (2013). Oncomir miR-125b Suppresses p14ARF to Modulate p53-Dependent and p53-Independent Apoptosis in Prostate Cancer. PLoS ONE. 8(4). e61064–e61064. 77 indexed citations
9.
Xue, Lingru, et al.. (2012). Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells. Oncogene. 32(35). 4130–4138. 145 indexed citations
10.
Chen, Liqun, Benjamin A. Mooso, Anisha Madhav, et al.. (2011). Dual EGFR/HER2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Withdrawal by Suppressing ErbB3. Clinical Cancer Research. 17(19). 6218–6228. 50 indexed citations
11.
Shi, Xu-Bao, et al.. (2011). Influence of Short Polyglutamine Tracts and p160 Coactivators on the Transactivation of the Androgen Receptor. Cancer Biotherapy and Radiopharmaceuticals. 26(2). 191–201. 3 indexed citations
12.
Shi, Xu‐Bao, Lingru Xue, Ai‐Hong Ma, et al.. (2010). miR‐125b promotes growth of prostate cancer xenograft tumor through targeting pro‐apoptotic genes. The Prostate. 71(5). 538–549. 165 indexed citations
13.
Shi, Xu‐Bao, Lingru Xue, June X. Zou, et al.. (2008). Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen‐independent growth of prostate cancer cells. The Prostate. 68(16). 1816–1826. 18 indexed citations
14.
Shi, Xu-Bao, Lingru Xue, Joy C. Yang, et al.. (2007). An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proceedings of the National Academy of Sciences. 104(50). 19983–19988. 390 indexed citations
15.
Shi, Xu‐Bao, Lingru Xue, Clifford G. Tepper, et al.. (2007). The oncogenic potential of a prostate cancer‐derived androgen receptor mutant. The Prostate. 67(6). 591–602. 14 indexed citations
16.
Tepper, Clifford G., Ruth L. Vinall, Lingru Xue, et al.. (2007). GCP‐mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor‐dependent and ‐independent mechanisms. The Prostate. 67(5). 521–535. 30 indexed citations
17.
Xue, Lingru, Jian Lü, Qian Cao, Charanjit Kaur, & Eng‐Ang Ling. (2006). Nestin expression in Müller glial cells in postnatal rat retina and its upregulation following optic nerve transection. Neuroscience. 143(1). 117–127. 43 indexed citations
18.
Xue, Lingru, Jian Lü, Qian Cao, et al.. (2006). Müller glial cells express nestin coupled with glial fibrillary acidic protein in experimentally induced glaucoma in the rat retina. Neuroscience. 139(2). 723–732. 82 indexed citations
19.
Winicov, Ilga, Babu Valliyodan, Lingru Xue, & J. Kenneth Hoober. (2004). The MsPRP2 promoter enables strong heterologous gene expression in a root-specific manner and is enhanced by overexpression of Alfin�1. Planta. 219(6). 925–935. 26 indexed citations
20.
Fast, Naomi M., Lingru Xue, Scott E. Bingham, & Patrick J. Keeling. (2002). Re‐examining Alveolate Evolution Using Multiple Protein Molecular Phylogenies. Journal of Eukaryotic Microbiology. 49(1). 30–37. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ellen van Rooijen Breakdown of academic impact, for papers by Ian Giddings Breakdown of academic impact, for papers by Adnan Derti Breakdown of academic impact, for papers by Yuko Matsushita Breakdown of academic impact, for papers by Valery Tarasov Breakdown of academic impact, for papers by Michael Mitchell Breakdown of academic impact, for papers by Christer Einvik Breakdown of academic impact, for papers by Véronique Fafeur Breakdown of academic impact, for papers by Edwin H. Rodriguez Breakdown of academic impact, for papers by Terhi Jokilehto
Rankless by CCL
2026